Type II diabetes mellitus: no longer just adults

I Libman1, S A Arslanian

  • 1Department of Pediatrics, Children's Hospital, University of Pittsburgh, Pennsylvania, USA.

Pediatric Annals
|September 25, 1999
PubMed

Insights

Type II diabetes is increasingly diagnosed in children, necessitating a comprehensive understanding of its pediatric epidemiology, characteristics, and management. Addressing this growing challenge requires focused research on screening and prevention strategies for pediatric diabetes.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Background:

  • Type II diabetes mellitus (T2DM) is increasingly prevalent in pediatric populations, shifting from a historically adult-onset disease.
  • This trend poses unique challenges for healthcare systems and requires specialized knowledge regarding T2DM in children.
  • Understanding the evolving landscape of pediatric T2DM is crucial for effective public health interventions.

Purpose of the Study:

  • To highlight the critical need for enhanced understanding of T2DM in children.
  • To outline key areas requiring investigation: epidemiology, clinical characteristics, treatment, screening, and prevention.
  • To prepare healthcare professionals for the challenges of pediatric diabetes management in the 21st century.

Main Methods:

  • This abstract outlines a conceptual framework rather than presenting empirical data.
  • It emphasizes the necessity of epidemiological studies in pediatric populations.
  • It calls for detailed characterization of T2DM in children, including phenotypic, biochemical, metabolic, and autoimmune aspects.

Main Results:

  • The abstract does not present specific results but identifies critical knowledge gaps.
  • It underscores the growing incidence of T2DM in childhood.
  • It highlights the need for data on disease characteristics and progression in pediatric patients.

Conclusions:

  • A comprehensive understanding of pediatric Type II diabetes mellitus is urgently required.
  • Future efforts must focus on epidemiology, clinical phenotypes, therapeutic strategies, high-risk population screening, and prevention.
  • Addressing these aspects is essential for managing the rising challenge of pediatric diabetes.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.